Huda Y. Zoghbi - 16 Mar 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/Huda Y. Zoghbi
Issuer symbol
REGN
Transactions as of
16 Mar 2022
Transactions value $
-$566,160
Form type
4
Filing time
18 Mar 2022, 16:14:46 UTC
Previous filing
05 Jan 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $784K +2K +184.84% $391.92 3.08K 16 Mar 2022 Direct F1
transaction REGN Common Stock Sale -$1.35M -2K -64.89% $675.00 1.08K 16 Mar 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2K -48.58% $0.00 2.12K 16 Mar 2022 Common Stock 2K $391.92 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.